Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Genomic Valley Biotech Ltd

GVBL
BSE
24.25
0.00%
Last Updated:
30 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Genomic Valley Biotech Ltd

GVBL
BSE
24.25
0.00%
30 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
7Cr
Close
Close Price
24.25
Industry
Industry
Floriculture/Tissue Culture
PE
Price To Earnings
PS
Price To Sales
15.12
Revenue
Revenue
0Cr
Rev Gr TTM
Revenue Growth TTM
-16.95%
PAT Gr TTM
PAT Growth TTM
-112.50%
Peer Comparison
How does GVBL stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
GVBL
VS

Quarterly Results

Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
100000000000
Growth YoY
Revenue Growth YoY%
-94.2250.0-94.0-100.0166.7200.0450.0-43.8-57.1-77.3
Expenses
ExpensesCr
000000000000
Operating Profit
Operating ProfitCr
100000000000
OPM
OPM%
93.050.042.950.081.371.468.20.022.20.020.0
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
100000000000
Tax
TaxCr
000000000000
PAT
PATCr
100000000000
Growth YoY
PAT Growth YoY%
553.3-93.5-66.7102.3-104.1333.3650.0700.0-100.0-84.6-100.0-93.8
NPM
NPM%
98.050.028.650.081.371.472.7-30.822.20.020.0
EPS
EPS
3.10.10.10.1-0.10.40.50.5-0.30.10.00.0

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
000111003010
Growth
Revenue Growth%
-65.2259.0304.834.765.7-14.1-75.4-66.13,758.2-93.9411.3-41.9
Expenses
ExpensesCr
011010002000
Operating Profit
Operating ProfitCr
000001001000
OPM
OPM%
-248.6-421.6-23.416.942.065.0-66.3-535.532.38.952.16.1
Other Income
Other IncomeCr
000000010000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
000000-101000
Tax
TaxCr
000000000000
PAT
PATCr
000000-101000
Growth
PAT Growth%
-318.5-3,871.679.5149.7582.023.0-295.598.37,040.5-97.72,245.5-114.0
NPM
NPM%
-27.8-307.1-15.55.723.633.8-268.7-13.223.89.242.2-10.2
EPS
EPS
0.0-1.1-0.20.10.80.9-1.80.02.10.11.2-0.1

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
333333333333
Reserves
ReservesCr
221122100011
Current Liabilities
Current LiabilitiesCr
111101101100
Non Current Liabilities
Non Current LiabilitiesCr
111122210000
Total Liabilities
Total LiabilitiesCr
666778844444
Current Assets
Current AssetsCr
000000013333
Non Current Assets
Non Current AssetsCr
666778732122
Total Assets
Total AssetsCr
666778844444

Cash Flow

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
0-101-101-2-100
Investing Cash Flow
Investing Cash FlowCr
-110-100-24200
Financing Cash Flow
Financing Cash FlowCr
0000100-2-100
Net Cash Flow
Net Cash FlowCr
-10000000000
Free Cash Flow
Free Cash FlowCr
0-100-1003100
CFO To PAT
CFO To PAT%
-1,088.7205.3-508.22,561.3-446.1152.9-265.622,799.3-120.1-132.27.5
CFO To EBITDA
CFO To EBITDA%
-121.6149.5-337.7868.5-250.779.5-1,075.4563.6-88.6-136.26.1

Ratios

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
0000000001118
Price To Earnings
Price To Earnings
0.00.00.00.00.00.00.00.00.0694.250.1
Price To Sales
Price To Sales
0.00.00.00.00.00.00.00.00.062.421.3
Price To Book
Price To Book
0.00.00.00.00.00.00.00.00.03.04.6
EV To EBITDA
EV To EBITDA
-7.7-1.6-6.87.33.42.6-11.10.0-0.1718.740.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
83.233.177.992.495.2108.060.897.341.8100.076.1
OPM
OPM%
-248.6-421.6-23.416.942.065.0-66.3-535.532.38.952.1
NPM
NPM%
-27.8-307.1-15.55.723.633.8-268.7-13.223.89.242.2
ROCE
ROCE%
-0.2-6.5-1.31.13.85.9-5.41.418.40.411.3
ROE
ROE%
-0.2-7.3-1.50.84.95.7-12.5-0.318.40.49.1
ROA
ROA%
-0.1-5.5-1.10.53.23.6-7.3-0.314.70.38.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **Overview** Genomic Valley Biotech Ltd. (GVBL) is a diversified biotechnology company integrating **genomics, artificial intelligence (AI), and advanced agricultural technologies** to drive innovation across **healthcare, agriculture, and industrial biotechnology**. Headquartered in India, GVBL operates at the intersection of science, technology, and sustainability, offering B2B research services and B2C personalized solutions in genomics and high-tech farming. --- ### **Core Business Segments** #### **1. Genomic Healthcare & Molecular Diagnostics** GVBL leverages **Next-Generation Sequencing (NGS)** and **AI-driven bioinformatics** to provide precision medicine and early disease detection, with a strong focus on oncology. - **Advanced Genomic Testing Services (as of Dec 2024):** - Whole Genome Sequencing - Exome Sequencing - Targeted Sequencing Panels - Gut Microbiome Analysis - Genetic Risk Screening for cancer, diabetes, cardiovascular diseases, and hereditary disorders - **Oncology Focus:** - AI-powered cancer diagnostics and personalized treatment plans based on genetic profiling - Discovery of novel biomarkers and therapeutic targets using NGS and machine learning - Development of **radiogenomics** platforms combining imaging and genomic data for improved cancer diagnosis and therapy personalization - **Genetic Counseling & Preventive Care:** - Offers genetic counseling to help patients interpret results and make informed healthcare decisions - Supports preventive healthcare through early identification of genetic predispositions - **Strategic Collaborations:** - Partnership with **Artemis Hospital, Gurgaon**, for access to state-of-the-art NGS wet-lab facilities - Plans to build an **in-house wet-lab** for NGS and Molecular Genetics to scale operations and reduce turnaround time - **R&D Strategy:** - Focus on translational research in **human genomics and oncology** - Integration of **AI/ML** to accelerate genomic data analysis and improve diagnostic accuracy - Extramural research collaborations with academic and industry partners to advance genomic medicine --- #### **2. Research Process Outsourcing (RPO) & Biotech Innovation** GVBL serves as a global partner for genomic research, offering end-to-end RPO services. - **RPO Services:** - Advanced genomic data analysis using dedicated bioinformatics teams and proprietary software tools - Support for global researchers in NGS-based studies and AI-integrated diagnostics - **Future Vision:** - Position GVBL as a **global hub for biotech innovation**, integrating **genomics, AI, and IT** - Expand RPO offerings to support pharmaceutical clients in **targeted drug development and gene therapy** - Pioneer scalable **biomanufacturing processes** for biologics and regenerative medicines --- #### **3. Agri-Tech & Sustainable Farming Solutions** GVBL is a leader in **modern, sustainable agriculture**, combining agri-technology with entrepreneurship to empower farmers and meet market demand. - **High-Tech Cultivation Technologies:** - **Environment-controlled polyhouses** for year-round cultivation - **Nutrient Film Technique (NFT)** for leafy greens and herbs - **Deep Flow Technique (DFT)** for tomatoes, cucumbers, and larger crops - **Plant Tissue Culture Laboratory** for high-yield, disease-free planting material - **Innovative Pest Management:** - Collaboration with an Israeli partner to introduce a **spray-free, lure-based pest control system** targeting female oriental fruit flies using Gravity-Controlled Fluid Release (GCFR) - Eliminates chemical spraying, promoting organic and eco-friendly farming - **Drone & Precision Agriculture:** - Active implementation of **drone technology** from Israel for field mapping, crop monitoring, and precision spraying - Use of **IoT, GPS, and satellite imagery** for data-driven farm management and input optimization - **Farmers Producer Company (FPC):** - Established in 2020–2023, aggregating **~300 small farmers** into a corporate platform - Ensures **minimum profit guarantees** for farmers and shared business returns - Produces high-value fruits, vegetables, and medicinal plants (e.g., Aloe vera) - **Agri Consultancy & Services:** - Offers **tailored agri-farming advisory** to farmers and High-Net-Worth Individuals (HNIs) - Provides **turnkey cultivation projects**, including land prep, polyhouse setup, crop selection, and buy-back assurance - Operates **Khad Beej Bhandar** – a high-tech agri-input shop --- #### **4. Integrated Farm-to-Consumer Ecosystem** GVBL has built a vertically integrated agricultural value chain from farm to consumer. - **Farm 2 Doorstep (farm2doorstep.com):** - Direct-to-consumer online platform delivering fresh, chemical-free produce to households in the **National Capital Region (NCR)** - Eliminates middlemen, reduces costs, and ensures superior quality - Supported by in-house packaging and logistics - **Supply Chain Strategy:** - Focus on **five pillars**: product quality, customer service, cost efficiency, innovation, and sustainability - Marketing partnerships with **retail chains and online marketplaces** to expand reach - Sale agreements for tissue culture plantlets and horticultural produce --- #### **5. Capacity Building & Education** GVBL is committed to building a skilled workforce in agriculture and biotechnology. - **GVBL Institute of High-Tech Agriculture & Biotechnology:** - Established as an **Agricultural Training Centre** in collaboration with **Eden Horticulture Services, Karnal** - Offers **paid training programs** for farmers and agri-entrepreneurs through the **Agri Skill Development Centre** - **Centre of Excellence for Horticulture (Karnal, Haryana):** - Equipped with poly houses, NFT/DFT systems, and a fully functional tissue culture lab - Serves as a model for **technology-driven, profitable farming** --- ### **Strategic Initiatives (Dec 2024 Outlook)** - **Dual Market Strategy:** Expand **B2B research collaborations** while strengthening **B2C personalized genetic and wellness services** - **Wet-Lab Expansion:** Establish in-house NGS and Molecular Genetics lab to reduce dependency and enhance data velocity - **FaaS (Farming as a Service):** Develop affordable, technology-driven farm management solutions for small and commercial farmers - **Global RPO Leadership:** Scale Research Process Outsourcing to serve international genomics projects - **Sustainability Integration:** Advance climate-resilient farming practices and reduce agricultural carbon footprint --- ### **Key Achievements (2020–2023)** | Year | Milestones | |------|-----------| | **2020** | Formation of Farmers Producer Company (300 farmers), launch of Plant Tissue Culture Lab, entry into greenhouse cultivation | | **2021** | Establishment of Centre of Excellence, launch of Farm 2 Doorstep, initiation of drone tech and Israeli pest control partnerships | | **2023** | Expansion of FPC, secured retail & e-commerce distribution, signing of Israeli tech agreements, launch of Agri Skill Development Centre |